SCHEMBL30633377

SCHEMBL30633377

CC(C)(C)c1ccc(NC(=O)Nc2cc(-c3ccc4[nH]nc(N)c4c3)ccn2)cc1.CCN(C(=O)O)c1cc(-c2ccc3[nH]nc(N)c3c2)ccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 6/20 0.51
▸ DYRK1A Q13627 6/20 0.40
▸ PLK4 O00444 4/20 0.40
▸ ROCK2 O75116 4/20 0.40
▸ JAK3 P52333 4/20 0.40
▸ MARK2 Q7KZI7 4/20 0.40
▸ AURKB Q96GD4 4/20 0.40
▸ DAPK3 O43293 3/20 0.40
▸ DYRK3 O43781 3/20 0.40
▸ MAP4K4 O95819 3/20 0.40
▸ CDK1 P06493 3/20 0.40
▸ CDK2 P24941 3/20 0.40
▸ MARK3 P27448 3/20 0.40
▸ TYK2 P29597 3/20 0.40
▸ CLK2 P49760 3/20 0.40
▸ CDK5 Q00535 3/20 0.40
▸ PRKCD Q05655 3/20 0.40
▸ ROCK1 Q13464 3/20 0.40
▸ PKN2 Q16513 3/20 0.40
▸ PRKD2 Q9BZL6 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30633303 0.91 JAK2 (0.48) JAK2DYRK1APLK4ROCK2JAK3
SCHEMBL30633306 0.90 CNR1 (0.51) JAK2DYRK1APLK4ROCK2JAK3
SCHEMBL26685947 0.89 JAK2 (0.62) JAK2DYRK1APLK4ROCK2JAK3
SCHEMBL30633384 0.89 JAK2 (0.62) JAK2DYRK1APLK4ROCK2JAK3
SCHEMBL30633315 0.88 JAK2 (0.46) JAK2DYRK1APLK4ROCK2JAK3
SCHEMBL30633326 0.86 DYRK1A (0.45) JAK2DYRK1ACLK2MAPK1WNT1
SCHEMBL30633336 0.85 KDR (0.51) JAK2PLK4ROCK2MARK2AURKB
SCHEMBL30633386 0.84 JAK2 (0.41) JAK2DYRK1APLK4ROCK2JAK3
SCHEMBL30633320 0.84 KDR (0.46) JAK2DYRK1APLK4ROCK2JAK3
SCHEMBL30633368 0.80 JAK2 (0.38) JAK2DYRK1APLK4ROCK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback